2012 american society of hematology state-of-the-art symposium

Download 2012 American Society of Hematology State-of-the-Art Symposium

Post on 25-May-2015




0 download

Embed Size (px)


  • 1. Sp Lo He eci ok on ma al C ins Fri to on iddle SA ay m ogy sult !S orin ninCo atiCh g urs ve ic prag ieo! or to2012 ASH State-of-the-Art SymposiumRecent Advances in Hematologic Malignancies Including a Special Focus on ThrombosisChicago Los Angeles September 28-29, 2012 October 12-13, 2012 Chicago, IL Los Angeles, CA Sheraton Chicago Hotel & Towers Loews Hollywood HotelThese meetings are sponsored by the American Society of Hematology (ASH) and presented in partnershipwith the following societies: Association of Northern California Oncologists Michigan Society of Hematology and Oncology Illinois Medical Oncology Society Missouri Oncology Society Indiana Oncology Society Nevada Oncology Society Iowa Oncology Society The Arizona Clinical Oncology Society Medical Oncology Association of Southern California

2. Greetings from the Program Co-ChairsGreetings,We are pleased to invite you to the 2012 ASH State-of-the-Art Symposium. As the onlynational organization focused on the unique needs of hematologists, ASH is committed toproviding educational experiences tailored to your requirements.This clinically focused, CME-accredited symposium is designed to offer the same high-caliber educational content for which the ASH annual meeting is known. In addition,the limited attendance for this meeting allows for increased interaction and networkingopportunities. We encourage you to take advantage of the various program breaks as well as the Lunch with the Experts.This years program will focus on the newest treatment options for hematologic malignancieswith a special focus on thrombosis. Topics will include thrombocytopenia, myelodysplasticsyndromes, and lymphoma. The speakers are experts in the field and are carefully selected by ASH for their breadth of knowledge in hematology.We look forward to hearing your feedback on the program, specifically related to improvingyour practice strategies and other ways ASHs continuing education activities can help meetyour educational needs.Thank you for your interest in the 2012 ASH State-of-the-Art Symposium and we hope to see you this fall!Sincerely yours,Nancy L. Bartlett, MDThomas L. Ortel, MD, PhD2012 ASH State-of-the-Art Symposium 2012 ASH State-of-the-Art SymposiumProgram Co-Chair Program Co-ChairPartnerSocieties: 3. General Informationabout the ASH State-of-the-Art SymposiumIn 2004, ASH launched the first State-of-the-Art Symposium (SAS).The one-and-a-half-day program, held in the fall each year, is designedto provide practitioners with an update on advances in the treatmentof blood diseases with the intent of addressing educational gaps andimproving competence in daily hematology practice.The SAS provides high-quality, up-to-date, evidence-based continuingmedical education that spans the medical field and practice ofhematology. The smaller, clinically focused program format providesattendees with ample opportunities to discuss their actual patientcases and practice challenges with experts in the field. Additionally, inorder to enhance the exchange of program content, panel discussionsand Lunch with the Experts are included in the meeting content.Learning ObjectivesUpon participation in this activity, attendees will be able to: Examine advances in clinical and translational hematologic research Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with blood diseases Implement new patient management and care strategies or revise existing ones based upon knowledge gained at the 2012 ASH State-of-the-Art SymposiumContinuing Medical Education (CME)ASH is accredited by the Accreditation Council for Continuing MedicalEducation to provide continuing medical education for physicians.ASH designates this live educational activity for a maximum of 10AMA PRA Category 1 Credits. Physicians should claim only thecredit commensurate with the extent of their participation in the activity.Physicians not licensed in the U.S. who participate in this CME activityare also eligible for AMA PRA Category 1 Credits.Instructions for obtaining a certificate awarding AMA PRA Category 1Credits or a certificate of attendance will be provided at the meeting site. 4. September 28-29, 2012October 12-13, 2012Program Schedule Sheraton Chicago Hotel & Towers Chicago, ILLoews Hollywood HotelLos Angeles, CAFridaySATURDAY12:00 noon Registration and Exhibits Open/Lunch7:30 a.m. Breakfast1:00 p.m. Welcome and Introductions 7:55 a.m. Welcome, Introductions, and Announcements1:10 p.m. Thrombopoietic Agents for Idiopathic8:00 a.m. Practice UpdateThrombocytopenia Terry B. Gernsheimer, MD 8:10 a.m. Diffuse Large B-Cell Lymphoma ShouldPuget Sound Blood Center, Seattle CancerCell of Origin and Molecular CharacteristicsCare Alliance, University of Washington Guide Therapy? John P. Leonard, MD1:50 p.m. American College of Chest PhysiciansWeill Medical College of Cornell University(ACCP) Antithrombotic Guidelines witha Focus on Perioperative Management of8:50 a.m. Central Nervous System Lymphoma Anticoagulant Therapy Treatment and Prevention James Douketis, MD Tracy Batchelor, MDMcMaster University Massachusetts General Hospital2:30 p.m. Thrombosis in Cancer Review of 9:30 a.m. Panel DiscussionCurrent American Society of ClinicalOncology (ASCO) and National9:50 a.m. Break and Exhibits OpenComprehensive Cancer Network 10:10 a.m. Follicular Lymphoma Who, When, and (NCCN) Treatment GuidelinesHow to Treat? Thomas L. Ortel, MD, PhD Nathan Fowler, MDDuke University Medical Center MD Anderson Cancer Center3:10 p.m. Panel Discussion10:50 a.m. Mantle Cell Lymphoma (MCL) Where Do3:40 p.m. Break and Exhibits New Agents Fit in the Management of MCL?Steven H. Bernstein, MD4:00 p.m. Myelodysplastic Syndromes The Role University of Rochesterof Stem Cell Transplant in the Era ofHypomethylating Agents11:30 a.m. Panel Discussion Joachim Deeg, MD 11:50 a.m. Lunch with the ExpertsFred Hutchinson Cancer Research Center(Speakers and Attendees)4:40 p.m. Acute Myeloid Leukemia Management 1:00 p.m. T-Cell Lymphoma Current Approaches of Older Patients and New Agents Gary J. Schiller, MD Barbara Pro, MDUCLA School of Medicine Fox Chase Cancer Center5:20 p.m. Panel Discussion1:40 p.m. Hodgkin Lymphoma Out with the Old5:40 p.m. Program Concludes for the Day (Radiation Therapy), In with the New(Brentuximab Vedotin) Nancy L. Bartlett, MDWashington University School of Medicine2:20 p.m. Chronic Lymphocytic Leukemia (CLL) Frontline and Salvage Therapy for Special Trainee Activities!High-Risk CLL ASH strongly encourages attendees who are currently Jacqueline C. Barrientos, MD enrolled in training programs at their institutions to Long Island Jewish Medical Center attend SAS. There will be dedicated time for trainees to network with speakers and a forum to discuss3:00 p.m. Panel Discussion specific cases and questions. Please see staff on site 3:30 p.m. Symposium Adjourned for more details about these activities. 5. Registration InformationIn order to maximize each participants experience, attendance at each of the ASH State-of-the-Art Symposia islimited. Advance registration is strongly encouraged. Your registration fee includes admission to the educationalsessions, access to the exhibit hall, two lunches, breakfast on Saturday, and CME processing.Registration RatesHow to Register AdvanceOn-Site Online at RegistrationRegistrationwww.hematology.org/sas12ASH Member $275 $325Payment by American Express,Member of Partner Society1 $275 $325MasterCard, or Visa is accepted.ASH Associate Member $135 $160By MailNon-Member Resident or Fellow 2 $150$175 Mail the registration form (availableAllied Health Professional3$175 $200at www.hematology.org/sas12)Non-Member $375 $450and payment by check only to theEmeritus/Honorary Member4 Complimentary Complimentaryaddress specified on the bottom of theregistration form.1 Partner societies include:Association of Northern California OncologistsAdvance Registration Deadlines:Illinois Medical Oncology Society Chicago: September 6Indiana Oncology SocietyIowa Oncology Society Los Angeles: September 20Medical Oncology Association of Southern CaliforniaMichigan Society of Hematology and Oncology Cancellation Deadlines:Missouri Oncology SocietyNevada Oncology Society Chicago: September 6The Arizona Clinical Oncology Society Los Angeles: September 20Members of partnering societies should email the ASH Customer RelationsDepartment at customerservice@hematology.org to receive instructions on the To request a refund, emailprocess and credentials needed for registering at this rate.customerservice@hematology.org. 2Non-member residents and fellows are required to provide a letter on theirIf your request is received by theinstitutions letterhead, signed by a training program director, which states thatthe registrant is currently enrolled in a training program. Registrants must email or meetings cancellation deadline specifiedfax a scanned copy of the letter to customerservice@hematology.org or 202-292-above, you will receive a refund minus a0250. Once trainee status has been verified, ASH will reply with instructions and$25 processing fee.credentials needed for registering at this rate.3 Allied health professionals should email the ASH Customer Relations Department Questions? at customerservice@hematology.org to receive instructions on the process andcredentials needed for registering online at this rate. Contact ASH Customer Relations4 ASH Emeritus and Honorary members should contact the ASH Customerat 202-776-0544 or emailRelations Department at 866-828-1231 (International callers dial 011+1+202- customerservice@hematology.org.776-0544) or email customerservice@hematology.org to register. 6. Hotel Information Chicago Los Angeles Chicago Hotel Accommodations Los Angeles Hotel Accommodations Sheraton Chicago Hotel & TowersLoews Hollywood Hotel 301 East North Water Street1755 North Hi


View more >